Diabetic Glomerulopathy: Pathogenesis and Management

Although not all renal disease that diabetic patients develop is due to diabetic glomerulosclerosis, the great majority of patients progressing to advanced renal failure suffer from diffuse or nodular (Kimmelstiel Wilson′s) diabetic glomerulosclerosis. This condition has become the single...

Full description

Bibliographic Details
Main Authors: Schmidt Susanne, Ismail Abdullah, Ritz Eberhard
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2000-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Subjects:
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2000;volume=11;issue=3;spage=405;epage=413;aulast=Schmidt
_version_ 1811262591707643904
author Schmidt Susanne
Ismail Abdullah
Ritz Eberhard
author_facet Schmidt Susanne
Ismail Abdullah
Ritz Eberhard
author_sort Schmidt Susanne
collection DOAJ
description Although not all renal disease that diabetic patients develop is due to diabetic glomerulosclerosis, the great majority of patients progressing to advanced renal failure suffer from diffuse or nodular (Kimmelstiel Wilson′s) diabetic glomerulosclerosis. This condition has become the single most frequent cause of end-stage renal failure in the Western world. Recent studies indicate that an interplay between genetic predisposition and other factors such as hyperglycemia, blood pressure, age, gender, smoking and ethnicity, predispose to nephropathy both in type 1 and type 2 diabetes mellitus. It has also become clear that trace albuminuria ("microalbuminuria") provides a unique opportunity to recognize incipient renal involvement early on, particularly in type 1 and less specifically in type 2 diabetes. Increasing evidence indicates that early intervention delays progression of nephropathy. Factors which promote progression of nephropathy include hypertension, proteinuria, smoking, poor glycemic control and, less certainly, high dietary protein intake and hyperlipidemia. The most important strategies to combat the medical catastrophe of increasing numbers of diabetic patients with end-stage renal failure include (i) prevention of diabetes (mainly type 2), (ii) glycemic control to prevent onset of renal involvement and (iii) meticulous antihypertensive treatment to avoid progression of nephropathy. Survival of diabetic patients on dialysis and after transplantation is inferior to that of non-diabetic patients, mainly because of high rate of cardiovascular death. There is consensus that in the absence of major vascular disease the best treatment is renal transplantation in the type 2 diabetic patient and combined kidney and pancreas transplantation in the type 1 diabetic patient.
first_indexed 2024-04-12T19:28:15Z
format Article
id doaj.art-4036b34cf0144ab3bf884d37f8ddda23
institution Directory Open Access Journal
issn 1319-2442
language English
last_indexed 2024-04-12T19:28:15Z
publishDate 2000-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Saudi Journal of Kidney Diseases and Transplantation
spelling doaj.art-4036b34cf0144ab3bf884d37f8ddda232022-12-22T03:19:24ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422000-01-01113405413Diabetic Glomerulopathy: Pathogenesis and ManagementSchmidt SusanneIsmail AbdullahRitz EberhardAlthough not all renal disease that diabetic patients develop is due to diabetic glomerulosclerosis, the great majority of patients progressing to advanced renal failure suffer from diffuse or nodular (Kimmelstiel Wilson′s) diabetic glomerulosclerosis. This condition has become the single most frequent cause of end-stage renal failure in the Western world. Recent studies indicate that an interplay between genetic predisposition and other factors such as hyperglycemia, blood pressure, age, gender, smoking and ethnicity, predispose to nephropathy both in type 1 and type 2 diabetes mellitus. It has also become clear that trace albuminuria ("microalbuminuria") provides a unique opportunity to recognize incipient renal involvement early on, particularly in type 1 and less specifically in type 2 diabetes. Increasing evidence indicates that early intervention delays progression of nephropathy. Factors which promote progression of nephropathy include hypertension, proteinuria, smoking, poor glycemic control and, less certainly, high dietary protein intake and hyperlipidemia. The most important strategies to combat the medical catastrophe of increasing numbers of diabetic patients with end-stage renal failure include (i) prevention of diabetes (mainly type 2), (ii) glycemic control to prevent onset of renal involvement and (iii) meticulous antihypertensive treatment to avoid progression of nephropathy. Survival of diabetic patients on dialysis and after transplantation is inferior to that of non-diabetic patients, mainly because of high rate of cardiovascular death. There is consensus that in the absence of major vascular disease the best treatment is renal transplantation in the type 2 diabetic patient and combined kidney and pancreas transplantation in the type 1 diabetic patient.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2000;volume=11;issue=3;spage=405;epage=413;aulast=SchmidtDiabetic glomerulopathyProteinuriaMicroalbuminuriaHypertensionGlomerulosclerosis.
spellingShingle Schmidt Susanne
Ismail Abdullah
Ritz Eberhard
Diabetic Glomerulopathy: Pathogenesis and Management
Saudi Journal of Kidney Diseases and Transplantation
Diabetic glomerulopathy
Proteinuria
Microalbuminuria
Hypertension
Glomerulosclerosis.
title Diabetic Glomerulopathy: Pathogenesis and Management
title_full Diabetic Glomerulopathy: Pathogenesis and Management
title_fullStr Diabetic Glomerulopathy: Pathogenesis and Management
title_full_unstemmed Diabetic Glomerulopathy: Pathogenesis and Management
title_short Diabetic Glomerulopathy: Pathogenesis and Management
title_sort diabetic glomerulopathy pathogenesis and management
topic Diabetic glomerulopathy
Proteinuria
Microalbuminuria
Hypertension
Glomerulosclerosis.
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2000;volume=11;issue=3;spage=405;epage=413;aulast=Schmidt
work_keys_str_mv AT schmidtsusanne diabeticglomerulopathypathogenesisandmanagement
AT ismailabdullah diabeticglomerulopathypathogenesisandmanagement
AT ritzeberhard diabeticglomerulopathypathogenesisandmanagement